ArticleThe Lancet regional health. Western Pacific2025
Impact of COVID-19 pandemic on cognitive decline in community-dwelling older adults in Shanghai: a longitudinal study from 2010 to 2024.
Article in The Lancet regional health. Western Pacific, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Morphological and Immunohistochemical Characteristics of Liver Inflammation in Patients with a History of COVID-19.Viruses · 2026Article
- Association of Excessive Daytime Sleepiness With Long-Term Incident Dementia: The Role of β-Amyloid and White Matter Injury.Alzheimer's & dementia (New York, N. Y.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In 2022, the rapid spread of the highly transmissible Omicron variant precipitated a dramatic surge in infections and a subsequent societal shutdown in Shanghai. It offers the opportunity to examine the impact of COVID-19 pandemic on cognitive decline among community-dwelling older adults. Methods: The Shanghai Aging Study enrolled 3792 community residents aged ≥ 50 from 2010 to 2012 in central Shanghai. Demographics, medical history, ApoE genotyping, and plasma phosphorylated tau 217 (p-tau217), phosphorylated tau 181 (p-tau181), and neurofilament light chain (NfL) were collected at baseline. Cognitive function assessment and MRI scans were conducted at baseline and follow-up visits from 2014 to 2024. Study periods were defined as Wave 1 (Jan.2010-Dec.2012, baseline, pre-pandemic), Wave 2 (Jan.2014-Mar.2022, pre-pandemic), and Wave 3 (Jun.2022-Dec.2024, post-pandemic). Event study, difference-in-differences (DID), and linear mixed-effects models were employed to evaluate the pandemic's impact on cognitive trajectories and brain structural changes. Findings: We observed steeper age-related declines of the Mini-Mental State Examination (MMSE) during Wave 3. The event study model adjusting for age, sex, and education, showed significant MMSE decline in Wave 3, but not in Wave 2. Declines were more pronounced in individuals with high baseline plasma p-tau217, p-tau181, and NfL, ApoE-ε4 carriers, those with multi-comorbidities, or long-term medication use. The DID and linear mixed-effects models with individual-specific follow-up data revealed accelerated declines in global cognition, executive and language function, and structural brain atrophy from Wave 2-3, compared with Wave 1-2. Interpretation: The COVID-19 pandemic significantly accelerated cognitive and brain structural changes in community-dwelling older adults, particularly among those with pre-existing AD pathology or health vulnerabilities. These findings provide evidence of COVID-19 pandemic-related cognitive decline and highlight the need for mechanistic research into how direct and indirect stressors converge to drive cognitive impairment. Funding: National Natural Science Foundation of China, Tianqiao and Chrissy Chen Institute, China National Postdoctoral Committee Fund, UCL: Wellcome Early-Career Award and Royal Society.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.